KILITCH DRUGS (INDIA)
Back to Cashflow Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-0.72 Cr | ₹7.03 Cr | ₹1.61 Cr | ₹0.85 Cr | ₹17 Cr |
What is the latest Cash Flow from Financing Activities ratio of KILITCH DRUGS (INDIA) ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹-0.72 Cr |
Mar2022 | ₹7.03 Cr |
Mar2021 | ₹1.61 Cr |
Mar2020 | ₹0.85 Cr |
Mar2019 | ₹17 Cr |
How is Cash Flow from Financing Activities of KILITCH DRUGS (INDIA) Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹-0.72 Cr | Negative | |
Mar2022 | ₹7.03 Cr | 335.44 | |
Mar2021 | ₹1.61 Cr | 89.88 | |
Mar2020 | ₹0.85 Cr | -94.96 | |
Mar2019 | ₹17 Cr | - |
Compare Cash Flow from Financing Activities of peers of KILITCH DRUGS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KILITCH DRUGS (INDIA) | ₹577.3 Cr | 1.1% | -2% | 103.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,920.0 Cr | -2.3% | -6.5% | 55.3% | Stock Analytics | |
CIPLA | ₹113,794.0 Cr | 4.1% | -4.8% | 55.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,860.0 Cr | 7.8% | 17.4% | 20.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,316.0 Cr | 4% | 0.8% | 29.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,380.9 Cr | -1.2% | -5.2% | 83.9% | Stock Analytics |
KILITCH DRUGS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KILITCH DRUGS (INDIA) | 1.1% |
-2% |
103.4% |
SENSEX | 0.9% |
1.5% |
23.6% |
You may also like the below Video Courses